- Details
- At the 26th Annual Prostate Cancer Foundation Scientific Retreat (PCF 2019), Professor June Chan joins Charles Ryan to discuss her work with patients on active surveillance (AS) for prostate cancer and a current ongoing study of lifestyle modification. Early data suggest that exercise after diagnosis could help with delaying or deterring prostate cancer recurrence or progression. The AS RCT study...
|
- Details
- Eric Ballon-Landa joins Gordon Brown at the first Rising Chief Residents Summit, a Large Urology Group Practice Association (LUGPA) organized meeting. The Rising Chief Resident Summit aims to support post-graduate year 4 and 5 residents during their transition to full-time practice. In this video discussion, Dr. Ballon-Landa shares why he chose to pursue urology. He shares advice on the interview...
|
- Details
- Sarah Wise, the Director of Research Operations at the Prostate Cancer Clinical Trials Consortium (PCCTC) sits down with Alicia Morgans to talk about the PCCTC, what the goals of the organization are, the benefit of the organization to patients, and how physicians, clinicians, and researchers can support what they are trying to do. The Prostate Cancer Clinical Trials Consortium (PCCTC) was initiat...
|
- Details
- At the Advanced Prostate Cancer Consensus Conference (APCCC 2019), Joe O'Sullivan joins Phillip Koo to discuss the onco-geriatric population, why it is referred to as a ticking time bomb, and the unique challenges it presents to the community. Biographies: Joe M. O'Sullivan, MD, FRCPI, FFRRSCI, FRCR, Professor of Radiation Oncology, Queen's University Belfast, Consultant Oncologist, Northern Irela...
|
- Details
- Robotic-Assisted Radical Prostatectomy (RARP) performed in patients with localized prostate cancer Related Content: Beyond the Abstract: Comparative Analysis of Functional Outcomes between Two Different Techniques after 1088 Robotic-Assisted Radical Prostatectomies in a High-Volume Cancer Center: A Clipless Approach Abstract: Comparative analysis of functional outcomes between two different techni...
|
- Details
- Nicholas James joins Alicia Morgans at the Advanced Prostate Cancer Consensus Conference (APCCC) to discuss systemic therapies for node-positive patients. Professor James discusses the three main questions to his presentation: What's the role of radiotherapy? What systemic therapies do you give with radiotherapy? Do you give ADT plus something else? Biographies: Professor Nicholas James BSc, MB, B...
|
- Details
- Professor of Medicine Oliver Sartor from Tulane University joins Charles Ryan to discuss several lutetium studies, radioligand therapy, and the VISION trial and where the state of lutetium currently stands both in the United States and globally with radiopharmaceutical treatment options. Biographies: A. Oliver Sartor, MD, Professor of Medicine and Medical Director, Tulane Cancer Center; C. E. and...
|
- Details
- Sima Porten discusses her work on using guided imagery to decrease anxiety for patients prior to undergoing major urologic surgery. Patients were asked to listen to guided imagery tapes and MP3s at least once a day for the two weeks leading up to their surgery. Patients were given an anxiety survey before receiving the tape and also the day before surgery. Patients also used a text messaging app t...
|
- Details
- Akash Patnaik, an Assistant Professor of Medicine at the University of Chicago joins Alicia Morgans to speak about his work and expertise with immunotherapy in prostate cancer. Dr. Patnaik and Dr. Morgans discuss the work that he is doing in the lab to better understand why some patients have exceptional responses to combining two different immunotherapies targeting CTLA-4 and PD-1 in prostate can...
|
- Details
- In this conversation with Alicia Morgans, Matthew Smith shares highlights from his 2019 European Society for Medical Oncology annual meeting, (ESMO) presentation. He presented the updated survival results from SPARTAN, A study of apalutamide (ARN-509) in men with non-metastatic castration-resistant prostate cancer (nmCRPC), a pivotal study which led to the approval of apalutamide for men with nmCR...
|
